June 14, 2017
Genentech to Highlight Actemra and Rituxan Data at EULAR Annual Congress
Read More
May 25, 2017
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
Read More
January 29, 2017
FDA Grants Priority Review Designation for Actemra in Giant Cell Arteritis
Read More
June 20, 2016
Global Genes Hosts 5th Annual Rare Patient Advocacy Summit and Tribute to Champions of Hope, Presented by PRA Health Sciences.
Read More
June 18, 2016
Genentech Phase III Study Shows Actemra Effective at Maintaining Steroid-Free Remission in Patients with Giant Cell Arteritis
Read More
September 3, 2015
Genentech on the Verge of First Biologic Treatment for Pemphigus Vulgaris
Read More
X